LATANOPROST-TIMOLOL DIN 02562324
Health Canada record
| Active ingredient(s) | LATANOPROST 50 MCG; TIMOLOL (TIMOLOL MALEATE) 5 MG |
|---|---|
| Dosage form | Solution |
| Route | Ophthalmic |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | S01ED51 TIMOLOL, COMBINATIONS |
| Original market date | |
| Current status date | 22-Oct-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Steri-Med Pharma Inc. — licence 100803, currently licensed, last inspection rating NC (2025-11-19).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LATANOPROST
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02534835 | AG-LATANOPROST | ANGITA PHARMA INC. | Solution | LATANOPROST 50 MCG | Marketed |
| 02296527 | APO-LATANOPROST | APOTEX INC | Solution | LATANOPROST 50 MCG | Marketed |
| 02453355 | JAMP LATANOPROST | JAMP PHARMA CORPORATION | Solution | LATANOPROST 50 MCG | Marketed |
| 02453770 | JAMP-LATANOPROST/TIMOLOL | JAMP PHARMA CORPORATION | Solution | LATANOPROST 50 MCG; TIMOLOL (TIMOLOL MALEATE) 5 MG | Marketed |
| 02563304 | LATANEO PF | ORIMED PHARMA INC | Solution | LATANOPROST 50 MCG | Approved |
| 02561972 | LATANOPROST | STERI-MED PHARMA INC. | Solution | LATANOPROST 50 MCG | Approved |
| 02553848 | LATANOPROST / TIMOLOL | JAMP PHARMA CORPORATION | Solution | LATANOPROST 50 MCG; TIMOLOL (TIMOLOL MALEATE) 5 MG | Marketed |
| 02513285 | M-LATANOPROST | MANTRA PHARMA INC | Solution | LATANOPROST 50 MCG | Marketed |
| 02514516 | M-LATANOPROST-TIMOLOL | MANTRA PHARMA INC | Solution | LATANOPROST 50 MCG; TIMOLOL (TIMOLOL MALEATE) 5 MG | Marketed |
| 02426935 | MED-LATANOPROST | GENERIC MEDICAL PARTNERS INC | Solution | LATANOPROST 50 MCG | Marketed |
| 02454505 | MED-LATANOPROST-TIMOLOL | GENERIC MEDICAL PARTNERS INC | Solution | LATANOPROST 50 MCG; TIMOLOL (TIMOLOL MALEATE) 5 MG | Marketed |
| 02421127 | MINT-LATANOPROST | MINT PHARMACEUTICALS INC | Solution | LATANOPROST 50 MCG | Approved |
| 02444666 | MINT-LATANOPROST/TIMOLOL | MINT PHARMACEUTICALS INC | Solution | LATANOPROST 50 MCG; TIMOLOL (TIMOLOL MALEATE) 5 MG | Approved |
| 02456230 | MONOPROST | LABORATOIRES THEA | Solution | LATANOPROST 50 MCG | Marketed |
| 02373041 | MYLAN-LATANOPROST | MYLAN PHARMACEUTICALS ULC | Solution | LATANOPROST 50 MCG | Marketed |
| 02373068 | MYLAN-LATANOPROST/TIMOLOL | MYLAN PHARMACEUTICALS ULC | Solution | LATANOPROST 50 MCG; TIMOLOL (TIMOLOL MALEATE) 5 MG | Marketed |
| 02341085 | RIVA-LATANOPROST | LABORATOIRE RIVA INC. | Solution | LATANOPROST 50 MCG | Marketed |
| 02367335 | SANDOZ LATANOPROST | SANDOZ CANADA INCORPORATED | Solution | LATANOPROST 50 MCG | Marketed |
| 02436256 | TEVA-LATANOPROST-TIMOLOL | TEVA CANADA LIMITED | Solution | LATANOPROST 50 MCG; TIMOLOL (TIMOLOL MALEATE) 5 MG | Marketed |
| 02246619 | XALACOM | BGP PHARMA ULC | Solution | LATANOPROST 50 MCG; TIMOLOL (TIMOLOL MALEATE) 5 MG | Marketed |
| 02231493 | XALATAN | BGP PHARMA ULC | Solution | LATANOPROST 50 MCG | Marketed |
| 02414155 | APO-LATANOPROST-TIMOP | APOTEX INC | Solution | LATANOPROST 50 MCG; TIMOLOL (TIMOLOL MALEATE) 5 MG | Dormant |
| 02404052 | BL LATANOPROST | BAUSCH & LOMB INC | Solution | LATANOPROST 50 MCG | Cancelled Pre Market |
| 02375508 | LATANOPROST | LABORATOIRE RIVA INC. | Solution | LATANOPROST 50 MCG | Cancelled Pre Market |
| 02489368 | LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION | HIKMA CANADA LIMITED | Solution | LATANOPROST 50 MCG; TIMOLOL (TIMOLOL MALEATE) 5 MG | Cancelled Post Market |
| 02398273 | LATANOPROST OPHTHALMIC SOLUTION | SANDOZ CANADA INCORPORATED | Solution | LATANOPROST 50 MCG | Cancelled Pre Market |
| 02489570 | LATANOPROST OPHTHALMIC SOLUTION | HIKMA CANADA LIMITED | Solution | LATANOPROST 50 MCG | Cancelled Post Market |
| 02422492 | MYLAN-LATANOPROST/TIMOLOL | MYLAN PHARMACEUTICALS ULC | Solution | LATANOPROST 50 MCG; TIMOLOL (TIMOLOL MALEATE) 5.0 MG | Cancelled Pre Market |
| 02317125 | PMS-LATANOPROST | PHARMASCIENCE INC | Solution | LATANOPROST 50 MCG | Dormant |
| 02404591 | PMS-LATANOPROST-TIMOLOL | PHARMASCIENCE INC | Solution | LATANOPROST 50 MCG; TIMOLOL (TIMOLOL MALEATE) 5 MG | Cancelled Pre Market |
| 02459205 | RIVA-LATANOPROST/TIMOLOL | LABORATOIRE RIVA INC. | Solution | LATANOPROST 50 MCG; TIMOLOL (TIMOLOL MALEATE) 5 MG | Cancelled Post Market |
| 02394685 | SANDOZ LATANOPROST/TIMOLOL | SANDOZ CANADA INCORPORATED | Solution | LATANOPROST 50 MCG; TIMOLOL (TIMOLOL MALEATE) 5 MG | Cancelled Post Market |
| 02414287 | TARO-LATANOPROST | TARO PHARMACEUTICALS INC | Solution | LATANOPROST 50 MCG | Cancelled Pre Market |
| 02254786 | TEVA-LATANOPROST | TEVA CANADA LIMITED | Solution | LATANOPROST 50 MCG | Cancelled Post Market |
| 02393328 | TEVA-LATANOPROST | TEVA CANADA LIMITED | Solution | LATANOPROST 50 MCG | Cancelled Pre Market |
| 02393921 | TEVA-LATANOPROST/TIMOLOL | TEVA CANADA LIMITED | Solution | LATANOPROST 50 MCG; TIMOLOL (TIMOLOL MALEATE) 5 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36229 | 2025-10-22 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement between two manufacturers |
International API supply for LATANOPROST
14 valid EDQM Certificates of Suitability from 14 holders. 24 active FDA Drug Master Files.
Request a quote for LATANOPROST-TIMOLOL